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OBJECTIVEdGiven the transient nature of exercise-induced improvements in insulin sensi-
tivity, it has been speculated that daily exercise is preferred to maximize the beneﬁts of exercise
for glycemic control. The current study investigates the impact of daily exercise versus exercise
performed every other day on glycemic control in type 2 diabetic patients.
RESEARCH DESIGN AND METHODSdThirty type 2 diabetic patients (age 60 6 1
years, BMI 30.4 6 0.7 kg/m2, and HbA1c 7.2 6 0.2%) participated in a randomized crossover
experiment. Subjects were studied on three occasions for 3 days under strict dietary standard-
ization but otherwise free-living conditions. Blood glucose homeostasis was assessed by contin-
uous glucose monitoring over 48 h during which subjects performed no exercise (control) or 60
min of cycling exercise (50% maximal workload capacity) distributed either as a single session
performed every other day or as 30 min of exercise performed daily.
RESULTSdThe prevalence of hyperglycemia (blood glucose.10 mmol/L) was reduced from
7:406 1:00 h:min per day (326 4% of the time) to 5:466 0:58 and 5:516 0:47 h:min per day,
representing 246 4 and 246 3% of the time, when exercise was performed either daily or every
other day, respectively (P, 0.001 for both treatments). No differences were observed between
the impact of daily exercise and exercise performed every other day.
CONCLUSIONSdA short 30-min session of moderate-intensity endurance-type exercise
substantially reduces the prevalence of hyperglycemia throughout the subsequent day in type
2 diabetic patients. When total work is being matched, daily exercise does not further improve
daily glycemia compared with exercise performed every other day.
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The level of glycemia (1,2), and par-ticularly postprandial glycemia (3–5),has been associated with the devel-
opment of cardiovascular complications
in type 2 diabetes. Therefore, glycemic
control is fundamental to type 2 diabetes
treatment. Since the effects of structured
exercise training on glycemic control have
been well established (6), exercise is
considered a cornerstone in type 2 diabe-
tes treatment.
A single bout of exercise lowers cir-
culating blood glucose concentrations
and reduces the prevalence of hyperglyce-
mic episodes throughout the subsequent
day in type 2 diabetic patients (7–9). These
glucoregulatory properties of exercise are
attributable to an increase in whole-body
insulin sensitivity, which has been re-
ported to persist for up to 48 h following
a single bout of exercise (10–12). As such,
the beneﬁts of exercise on long-term gly-
cemic control (i.e., HbA1c) can be largely
ascribed to the cumulative glucoregulatory
effects of each successive bout of exercise,
rather than the structural adaptive response
to prolonged exercise training (10,11). In
fact, the effects of more prolonged exercise
training on insulin sensitivity may be lost
entirely 6–8 days after cessation of training
(13,14). Therefore, regular exercise is
warranted to improve and/or maintain
long-term glycemic control. This is also
recognized by the recently updated exer-
cise guidelines of the American College of
Sports Medicine and the American Dia-
betes Association (15), which state that
exercise should be performed at least 3
days/week with no more than two con-
secutive days between exercise bouts.
Given the short-lived character of
exercise-induced improvements in in-
sulin action, it has even been speculated
that daily exercise would be the preferred
frequency of exercise to improve glycemic
control in type 2 diabetes (11,16). How-
ever, since most exercise intervention
studies typically divided the total amount
of exercise over three exercise sessions per
week (17), it is presently unclear whether
daily exercise sessions provide an equal or
additional beneﬁt with respect to glycemic
control compared with a less frequent ex-
ercise regimen. Moreover, shorter daily
exercise sessions may be preferred over
less frequent bouts of a longer duration
in more compromised type 2 diabetic
patients. These patients are commonly
characterized by a high prevalence of car-
diovascular comorbidities, polyneurop-
athy, and/or reduced exercise tolerance,
which generally reduce the capacity to
perform more prolonged bouts of exer-
cise. More information on the preferred
frequency of exercise would provide
health care professionals with a useful in-
strument to individualize and, as such, op-
timize exercise intervention programs to
treat type 2 diabetes.
The current study investigates the
impact of daily exercise versus exercise
performed every other day on glycemic
control throughout the day in insulin-
treated and non–insulin-treated type 2 di-
abetic patients. For this purpose,we applied
continuous glucose monitoring under stan-
dardized dietary, but otherwise free-living,
conditions over a 48-h period duringwhich
patients performed no exercise (control) or
60min of cycling exercise distributed either
as a single session performed every other
day (nondaily) or as 30min of exercise per-
formed daily (daily). We hypothesized that
daily exercise improves blood glucose ho-
meostasis to a greater extent comparedwith
the same amount of exercise performed
every other day.
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RESEARCH DESIGN AND
METHODSdThirty male type 2 dia-
betic patients were recruited to partici-
pate in a randomized crossover study.
Both non–insulin-treated (n = 16) and
insulin-treated (n = 14) type 2 diabetic
patients were selected. Exclusion criteria
were self-reported renal failure and liver
disease (hepatitis and cirrhosis), morbid
obesity (BMI .40 kg/m2), uncontrolled
hypertension (.160 mmHg systolic
and/or.100 mmHg diastolic blood pres-
sure), and a history of severe cardiovascu-
lar problems (myocardial infarction in the
last year or stroke). All subjects were in-
formed of the nature and the risks of the
experimental procedures before their
written informed consent was obtained.
The medical ethics committee of the
Maastricht University Medical Centre+
approved all clinical experiments.
Screening and pretesting
Non–insulin-treated patients performed
an oral glucose tolerance test (OGTT).
Blood glucose–lowering medication was
withheld 2 days prior to the OGTT. After
an overnight fast, subjects arrived at the
laboratory at 8:00 A.M. by car or public
transportation. A fasting blood sample
was obtained, after which the OGTT was
performed to determine type 2 diabetes
according to the American Diabetes Asso-
ciation criteria (18). Insulin-treated type 2
diabetic patients were screened with a
basal blood sample to determine their
fasting plasma glucose concentration
and HbA1c level. After blood sampling,
maximal workload capacity (Wmax) was
determined with an electromagnetically
braked cycle ergometer (Lode Excalibur,
Groningen, the Netherlands) during an
incremental exhaustive exercise test. Car-
diac function was monitored using a 12-
lead electrocardiogram.
Study design
Subjects participated in a randomized
crossover study consisting of three in-
tervention periods separated by at least 4
days. Each intervention period consisted
of 3 days during which the impact of
moderate-intensity cycling exercise (50%
Wmax) on 48-h blood glucose homeosta-
sis was assessed under standardized di-
etary, but otherwise free-living, conditions
(Fig. 1). All intervention periods were
identical with the exception of the fre-
quency and duration of the exercise ses-
sions. During one intervention period
(nondaily), a single 60-min bout of exer-
cise was performed at the beginning of the
48-h assessment. In the other intervention
period (daily), the same amount of exer-
cise was performed via two exercise ses-
sions of 30 min each. The ﬁrst 30-min
session was performed at the beginning
of the 48-h assessment and the second ses-
sion exactly 24 h later. In a third interven-
tion period (control), subjects performed
no exercise at all.
On day 1 of each intervention period,
subjects arrived at the laboratory at 7:30 A.M.
after an overnight fast. A continuous
glucose-monitoring device (GlucoDayS;
A. Menarini Diagnostics, Firenze, Italy)
was attached, and subjects received a
short training in capillary blood sam-
pling (Glucocard X Meter; Arkray, Kyoto,
Japan). After breakfast at 8:30 A.M., the ex-
ercise session was started at 10:00 A.M. for
both exercise treatments. At 11:15 A.M.,
subjects were free to go home and resume
their normal daily activities. On day 2,
subjects reported to the laboratory at
8:00 A.M. After breakfast at 8:30 A.M., the
exercise session was started at 10:00 A.M.
(only for the daily exercise experiment).
In case no exercise was performed at
10:00 A.M., subjects were rested in a chair.
At 11:15 A.M., subjects were free to go home
and resume their normal daily activities.
On days 1 and 2, venous blood samples
were obtained in fasting conditions (at
8:15 A.M.) and 2.5 h following breakfast
(at 11:00 A.M.). On day 3, subjects ar-
rived at the laboratory after 10:00 A.M.
for removal of the continuous glucose-
monitoring device (Fig. 1).
Exercise protocol
The exercise sessions consisted of either
30- or 60-min cycling at a constant
workload (Lode Excalibur). The applied
workload of 50%Wmax was based on pre-
vious studies fromour laboratory (19,20),
which have shown that this workload can
be maintained for 60 min by type 2 dia-
betic patients. In addition, these studies
reported that a workload of 50% Wmax
corresponds with ;60% of patients’
VO2max, with lactate concentrations re-
maining ,4 mmol/L (ranging from ;2.5
to 3.5 mmol/L over the 60-min course of
exercise [19,20]). Consequently, we as-
sumed that patients in the current study
would exercise below their anaerobic
threshold.
Diet and physical activity
All subjects were asked to maintain their
habitual physical activity patterns through-
out the experimental period but to refrain
from exhaustive physical labor and exercise
training for 2 days prior to and during
the experimental period. During the ex-
perimental periods, physical activity was
assessed using a validated triaxial acceler-
ometer (Philips DirectLife, Eindhoven, the
Netherlands) (21), worn in a belt around
the waist. Total physical activity, including
exercise, was determined by the sum of
accelerometer counts obtained over the
48-h assessment periods. Non–exercise-
associated physical activity was determined
in a similar fashion after discarding the time
periods between 10:00 and 11:00 A.M. on
days 1 and 2 (time of exercise treatment) in
all experimental periods.
During each experimental period,
subjects were provided with a healthy
standardized diet, composed according to
the American Diabetes Association dietary
recommendations for type 2 diabetes (22).
The diet consisted of threemeals and three
snacks per day, distributed in preweighed
packages and ingested at predetermined
time points to ensure a fully standardized
diet. The diet provided 10.36 0.1 MJ/day
consisting of 55% of energy from carbo-
hydrate, 14% from protein, and 31% from
fat. The diet was designed to meet the
individual energy requirements as calcu-
lated with the Harris and Benedict equa-
tion (1918) multiplied with a physical
activity level value of 1.4. The resulting en-
ergy requirements represent a sedentary
lifestyle.
Medication
Non–insulin-treated patients were treated
with metformin only (n = 10), metformin
combined with a sulfonylurea or thiazoli-
dinedione (n = 5), or diet only (n = 1).
Insulin-treated patients were treated
with an insulin pump (n = 2) or basal
(n = 1), biphasic (n = 3), or multiple (n = 8)
insulin injection regimens, with (n = 11)
or without (n = 3) combined use of oral
blood glucose–lowering medication. Oral
blood glucose–lowering medication and/
or exogenous insulin treatment was con-
tinued as normal throughout the entire
experimental period. Insulin-treated pa-
tients were explicitly asked not to deviate
from their habitual exogenous insulin
treatment schemes when exercise was
performed.
Blood sample analysis
Venous blood samples (5 mL) were col-
lected in EDTA-containing tubes and
centrifuged at 1,000g and 48C for 10 min.
Aliquots of plasma were immediately fro-
zen in liquid nitrogen and stored at2808C
until analyses. Plasma glucose concentrations
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(Roche, Basel, Switzerland) were deter-
mined with a COBAS FARA semiautomatic
analyzer (Roche). Insulin concentra-
tions were determined by radioimmuno-
assay (Linco, St Charles, MO) and were
only determined in the non–insulin-
treated diabetic patients. HbA1c content
was determined by high-performance
liquid chromatography (Bio-Rad Diamat,
Munich, Germany).
Statistics and data analysis
The data obtained by the continuous glu-
cose monitor were downloaded to a per-
sonal computer with GlucoDay software
(V3.2.2). Values reported by the continuous
glucose-monitoring device were conver-
ted into glucose values using the self-
monitored capillary blood glucose values,
which were obtained before each main
meal and before the night. The glycemic
proﬁles during the 48-hmonitoring period
(from 10:00 A.M. on day 1 to 10:00 A.M. on
day 3) were used to determine average glu-
cose concentrations, the prevalence of hy-
perglycemia (glucose concentrations .10
mmol/L), and the prevalence of hypoglyce-
mia (glucose concentrations,3.9mmol/L).
Treatment effects were assessed by one-
way repeated-measures ANOVA, with ex-
ercise treatment as within-subject factor.
When applicable, pairwise comparisons
with Bonferroni correction were applied
to locate differences between interventions.
Statistical comparisons were considered
signiﬁcant when P values were ,0.05.
All statistical calculations were performed
using the SPSS 15.0.1.1 software package.
Unless otherwise speciﬁed, shown results
represent means 6 SEM.
RESULTSdSubjects’ characteristics
are shown in Table 1. Insulin- and non–
insulin-treated type 2 diabetic patients
were comparable with respect to age,
BMI, HbA1c, and Wmax. Non–insulin-
treated patients had been diagnosed with
type 2 diabetes for 5 6 1 years, whereas
insulin-treated patients had been diag-
nosed for 12 6 2 years (P = 0.001) and
had been treated with exogenous insulin
for 5 6 2 years.
Experimental periods
All 30 subjects successfully completed
each of the three experimental treatments
(control and daily and nondaily exercise).
Subjects were compliant with respect to
their medication and standardized diet,
as veriﬁed by dietary records. Both dos-
ing and timing of blood glucose–lower-
ing medication were identical during the
three experimental periods, since these
factors were registered during the ﬁrst ex-
perimental period and replicated during
the second and third periods. During the
experimental periods, insulin-treated pa-
tients were using 0.84 6 0.11 units
insulin/kg body wt/day.
Physical activity level
Total physical activity recorded over the
48-h period in both the daily and nondaily
experimental conditions (2,4676 131 and
2,5556 121 kilocounts [kcounts], respec-
tively) was higher when comparedwith the
control experiment (2,3046 128 kcounts;
main effect P = 0.004). However, non–
exercise-associated physical activity in both
the daily and nondaily experimental con-
ditions (2,205 6 121 and 2,307 6 117
kcounts) did not differ compared with the
control experiment (2,2396 128 kcounts;
main effect P = 0.29).
Plasma glucose and insulin
concentrations
Fasting plasma glucose and insulin con-
centrations assessed on the ﬁrst day of
each intervention period did not differ
between treatments. Postbreakfast plasma
glucose and insulin concentrations on
day 1 showed a dose-dependent effect
after performing 30 and 60 min of exer-
cise, respectively (main effect P , 0.001
for both glucose and insulin) (Fig. 2). On
the second day, fasting plasma glucose
and insulin concentrations did not differ
between treatments, indicating that a sin-
gle bout of exercise performed on the pre-
vious day does not affect fasting plasma
glucose and insulin concentrations. Post-
breakfast plasma glucose and insulin con-
centrations on day 2 were lower in the
daily exercise experiment compared with
Figure 1dSchematic overview of an experimental period. A continuous glucose-monitoring device was inserted ( ) at 7:30 A.M. on day 1 and
removed ( ) after 10:00 A.M. on day 3. During an experimental period, subjects’ blood glucose concentrations were monitored over a 48-h period
during which subjects performed no exercise (control), or 60 min of cycling exercise (50% Wmax), distributed either as a single session at the
beginning of the monitoring period (nondaily) or as 30min per day (daily). The exercise sessions ( ) were initiated at 10:00 A.M. In case no exercise
( ) was performed in the morning, subjects were resting in a chair. On days 1 and 2 of each experimental period, subjects consumed breakfast at the
laboratory and were free to go home and resume their normal daily activities after 11:15 A.M. During an experimental period, subjects consumed
a standardized diet with main meals ( ) ingested at 8:30 A.M., 12:30 P.M., and 6:00 P.M.
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the control and nondaily exercise treat-
ment (P , 0.05 for both glucose and in-
sulin) (Fig. 2). Interestingly, also in the
nondaily exercise experiment, when a
60-min bout of exercise was performed
on the previous day, postbreakfast glucose
concentrations were signiﬁcantly lower
compared with the control treatment
(P = 0.022) (Fig. 2A).
24-h glucose concentrations
Average blood glucose concentrations
over the 48-h monitoring period were
reduced from 9.1 6 0.4 mmol/L in the
control experiment to 8.3 6 0.3 and
8.3 6 0.3 mmol/L in the nondaily and
daily exercise experiments, respectively
(P , 0.001 for both exercise treatments)
(Fig. 3A). No differences were observed in
the capacity of both exercise treatments to
lower average 48-h glucose concentra-
tions (P = 1.00). In addition, a similar ef-
fectiveness of both exercise interventions
was observed in the ﬁrst 24 h and second
24 h of the 48-h assessment period (Fig.
3A). The blood glucose–lowering effects
observed over 48 h did not differ between
the insulin- and non–insulin-treated type
2 diabetic patients (exercise 3 group in-
teraction P = 0.44).
Prevalence of hyperglycemia
Despite the continued use of glucose-
lowering medication and consumption
of a healthy diet, type 2 diabetic patients
experienced excessive hyperglycemia (glu-
cose concentrations exceeding 10mmol/L)
throughout a considerable part of the
day. In fact, hyperglycemia was experi-
enced for as much as 7:406 1:00 h:min
per day (7:27 6 1:34 and 7:54 6 1:23
h:min per day in the non–insulin-treated
and insulin-treated type 2 diabetic pa-
tients, respectively). The prevalence of
hyperglycemia was reduced from 7:40 6
1:00 to 5:46 6 0:58 and 5:51 6 0:47
h:min per day when exercise was per-
formed daily or nondaily (P , 0.001 for
both exercise treatments) (Fig. 3B). The
effects of exercise on hyperglycemia
were comparable between the insulin- and
non–insulin-treated subjects (exercise 3
group interaction P = 0.43). When the
effects of exercise over both the ﬁrst and
second 24 h of the 48-h assessment pe-
riod were calculated, daily and nondaily
exercise were equally effective in reduc-
ing the prevalence of hyperglycemia over
both the ﬁrst and second 24-h periods
(Fig. 3B).
Prevalence of hypoglycemia
Overall, hypoglycemia was prevalent for
an average of 0:466 0:18 h:min over the
48-h monitoring period, representing
2 6 1% of the total time. The prevalence
of hypoglycemia did not change when
nondaily or daily exercise was performed
during the 48-h period (1:00 6 0:14
and 0:59 6 0:14 h:min, respectively;
main effect P = 0.63). Although we did
not observe an exercise3 group interac-
tion (P = 0.54), the overall prevalence of
hypoglycemia was approximately three-
fold higher in the insulin-treated com-
pared with the non–insulin-treated type
2 diabetic patients (between-group effect
P = 0.012).
CONCLUSIONSdThe current study
shows that hyperglycemia is highly prev-
alent throughout the day in insulin- and
non–insulin-treated type 2 diabetic pa-
tients. A single bout of merely 30 min of
exercise is shown to substantially reduce
the prevalence of hyperglycemia through-
out the subsequent day. Thirty minutes of
daily exercise is as effective as more pro-
longed 60-min bouts of exercise performed
every other day to optimize glycemic con-
trol in type 2 diabetic patients.
The current study conﬁrms previous
reports (23,24) showing that postpran-
dial hyperglycemia is a largely under-
estimated problem in type 2 diabetes
treatment. Despite the continued use of
blood glucose–lowering medication and
the provision of a healthy, well-balanced
diet, type 2 diabetic patients were shown to
experience hyperglycemia for as much as
326 4% of the time (Fig. 3). This ﬁnding
translates to 7:40 6 1:00 h:min per day
during which blood glucose levels ex-
ceeded 10 mmol/L. The prevalence of
hyperglycemia was comparable in the
insulin-treated and non–insulin-treated
type 2 diabetic patients (7:54 6 1:23
and 7:276 1:34 h:min per day, respec-
tively), suggesting that neither oral
blood glucose–lowering medication nor
exogenous insulin provides sufﬁcient
protection against postprandial hyper-
glycemia. Given the strong and indepen-
dent relationship between postprandial
blood glucose increments and cardiovas-
cular events (3–5), more effective man-
agement of postprandial hyperglycemia
is warranted.
In the current study, we show that
just 30min ofmoderate-intensity exercise
substantially reduces the prevalence of hy-
perglycemia throughout the subsequent
day. A single bout of exercise reduced the
prevalence of hyperglycemic episodes by
nearly 2 h, from 7:40 6 1:00 to 5:46 6
0:58 h:min per day (Fig. 3B). Moreover,
average blood glucose concentrations
throughout the subsequent day were re-
duced by 0.8 mmol/L: from 9.1 to 8.3
mmol/L (Fig. 3A). These profound effects
of such a short exercise bout seem to be of a
magnitude similar to those reported in pre-
vious studies following more prolonged
bouts of exercise in both insulin-treated
(8,9) and non–insulin-treated (7,9) type 2
diabetic patients. Clearly, the prescription
of just 30 min of daily exercise represents
an effective interventional strategy to
Table 1dSubjects’ characteristics
Group Non–insulin treated Insulin treated P
n 16 14
Age (years) 60 6 2 60 6 2 0.914
Time since diagnosis of type 2 diabetes (years) 5.0 6 0.7 11.6 6 1.9 0.001
Time on insulin therapy (years) NA 5.1 6 1.6 NA
BMI (kg/m2) 29.8 6 0.9 31.1 6 1.0 0.337
HbA1c (%) 7.0 6 0.2 7.4 6 0.2 0.227
HbA1c (mmol/mol) 53 6 2 57 6 3 0.227
Fasting plasma glucose (mmol/L) 8.4 6 0.5 8.0 6 0.8 0.590
2-h postchallenge plasma glucose (mmol/L) 14.5 6 1.0 NA NA
Fasting plasma insulin (pmol/L) 137 6 15 NA NA
2-h postchallenge plasma insulin (pmol/L) 491 6 118 NA NA
OGIS index 272 6 14 NA NA
Systolic blood pressure (mmHg) 145 6 4 139 6 3 0.227
Diastolic blood pressure (mmHg) 79 6 2 78 6 2 0.725
Wmax (W/kg body wt) 1.9 6 0.1 1.8 6 0.2 0.286
Data are means 6 SEM unless otherwise indicated. In the non–insulin-treated diabetic patients, glucose,
insulin, and oral glucose insulin sensitivity (OGIS) indexwere determined from anOGTTperformed after 2 days
of discontinuation of habitual use of oral blood glucose–lowering medication. W, watts; NA, not applicable.
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reduce hyperglycemia and improve daily
glycemic control in type 2 diabetic pa-
tients. As such, the present ﬁndings high-
light the clinical relevance of exercising
at least 30 min per day, which has been
advocated by many exercise guidelines as
the minimal daily amount of exercise to
promote and/or maintain optimal health
(15,25,26).
The current study further extends on
previous work in this area by investigat-
ing the impact of the frequency of exercise
on glycemic control throughout the day.
A single bout of exercise stimulates blood
glucose disposal (27,28) and induces a tran-
sient increase in whole-body insulin sensi-
tivity for up to 48 h (29,30). Consequently,
it has been speculated that performing
exercise on a daily basis may be of even
greater beneﬁt with respect to glycemic
control compared with exercise bouts
performed less frequently (11,16).
Therefore, in the current study we com-
pared the impact of 30-min bouts of ex-
ercise performed daily with more
prolonged 60-min bouts of exercise per-
formed every other day on subsequent
glycemic control. The daily bouts of ex-
ercise were shown to be equally effective
in lowering postprandial hyperglycemia
as the more prolonged bouts of exercise
performed every other day (Fig. 3). Thus,
when total work is being matched, daily
exercise of short duration is equally effec-
tive as more prolonged bouts of exercise
performed less frequently. Consequently,
when exercise is not performed every
day, patients can compensate by per-
forming more prolonged bouts of exer-
cise every other day.
Both moderate-intensity exercise and
high-intensity exercise performed in the
postprandial state have been shown to
acutely decrease postprandial plasma glu-
cose and insulin concentrations (27,28).
In the current study, moderate-intensity
exercise was initiated in the early post-
prandial phase, 90 min after breakfast.
Postprandial plasma glucose and insulin
concentrations obtained 150 min after
breakfast were substantially lower when
prior exercise was performed. Interest-
ingly, both plasma glucose and insulin
concentrations obtained in this acute
postprandial phase were shown to be re-
duced in a dose-dependent manner after
performing 30 or 60min of exercise (Fig. 2).
The attenuated rise in postprandial plasma
glucose concentrations following exer-
cise is attributed to a greater glucose up-
take and subsequent storage and/or
oxidation (10,27). The concomitant re-
duction in circulating insulin levels
clearly reﬂects the impact of exercise on
stimulating insulin-independent glucose
disposal. In contrast to the acute phase,
a dose-response effect was not observed
over the entire 24 h period following exer-
cise. Both the 30- and 60-min exercise
bouts were equally effective in improving
glycemic control throughout the subse-
quent day (Fig. 3).
The strong blood glucose–lowering
effects induced by exercise may be associ-
ated with an augmented risk of developing
hypoglycemia in patients with advanced
type 2 diabetes (31,32). Particularly, the
combined glucose-lowering effects of exer-
cise and exogenous insulin or sulfonylureas
may increase the risk for hypoglycemic
Figure 2dAverage plasma glucose (A) and insulin (B) concentrations obtained in fasting con-
ditions and 2.5 h following breakfast on days 1 and 2 of an experimental period during which
subjects performed no exercise (control [▫]) or 60 min of cycling exercise (50% Wmax) dis-
tributed either as a single session per 2 days (nondaily [-]) or as 30 min per day (daily [G]).
Plasma glucose concentrations were determined in all type 2 diabetic patients (n = 30), whereas
plasma insulin concentrations were determined in non–insulin-treated type 2 diabetic patients only
(n = 16). *Signiﬁcantly different compared with the control trial (P , 0.05). †Signiﬁcantly
different compared with daily exercise (P , 0.05). ‡Signiﬁcantly different compared with non-
daily exercise (P, 0.05).
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episodes. Therefore, we also assessed the
prevalence of hypoglycemia in both the in-
sulin- and non–insulin-treated type 2 dia-
betic patients. Overall, the prevalence of
hypoglycemia (here deﬁned as blood
glucose concentrations ,3.9 mmol/L) was
approximately threefold higher in the
insulin- compared with the non–insulin-
treated type 2 diabetic patients (between-
group effect P = 0.012). However, exercise
did not increase the prevalence of hypogly-
cemic episodes (main effect P = 0.63), and
the response to exercise was not different
between insulin- and non–insulin-treated
type 2 diabetic patients (exercise 3 group
interaction P = 0.54). The absence of any
exercise-induced hypoglycemia is not sur-
prising, as we ensured that dietary intake
was well distributed over the day, with
meals and/or snacks ingested prior to and
immediately after exercise.
The current study holds several im-
portant implications for health care pro-
fessionals. Frequent short bouts of exercise
are equally effective to improve glycemic
control as less frequent exercise bouts of a
longer duration. Consequently, the total
amount of work performed seems to be of
prime importance with respect to glycemic
control. This view is supported by a re-
cent meta-analysis of Umpierre et al. (17),
which demonstrated greater improve-
ments in glycemic control (i.e., HbA1c)
following structured exercise training
with a total duration of .150 min per
week as opposed to ,150 min per
week. The balance between the frequency
and duration of exercise sessions, how-
ever, can be used as an instrument to op-
timize exercise prescription for the
individual patient. Depending on the
preference of the patient, the presence
of comorbidities, and overall training sta-
tus, more frequent short bouts of exercise
can be substituted for less frequent exer-
cise bouts of a longer duration or vice
versa. Short bouts of exercise may be par-
ticularly useful for patients suffering from
reduced exercise tolerance, polyneurop-
athy, and other diabetic comorbidities,
such as micro- and macrovascular compli-
cations,which generally reduce the feasibil-
ity of performing more prolonged exercise.
On the other hand, more prolonged bouts
of exercise may offer a time-efﬁcient al-
ternative to daily exercise and might be
more feasible for many other diabetic pa-
tients who have difﬁculty scheduling daily
exercise in their work routine.
Caution should be taken when trans-
lating our ﬁndings to the entire popula-
tion of patients with type 2 diabetes, since
patients included in the current study
were relatively healthy. Patients suffer-
ing from severe long-term complications
and reduced exercise tolerance may not be
able to perform exercise with the duration
and intensity applied in the current study.
It should be noted, however, that partic-
ularly these patients would beneﬁt from
the ﬁnding that frequent short bouts are
equally effective with respect to glycemic
control compared with more prolonged
bouts of exercise (11). Nevertheless, the
feasibility and effectiveness of an exercise
regimen with frequent short bouts of ex-
ercise remain to be established in type 2
diabetic patients suffering from long-term
complications.
In conclusion, 30 min of exercise sub-
stantially reduces the prevalence of hyper-
glycemia throughout the subsequent day in
both insulin- and non–insulin-treated type
2 diabetic patients. Short bouts of exercise
performed on a daily basis are equally ef-
fective as more prolonged bouts of exercise
Figure 3dAverage 24-h glucose concentrations (A) and the prevalence of hyperglycemia (B)
in type 2 diabetic patients (n = 30) determined over the ﬁrst 24 h, second 24 h, and total 48 h
of the assessment period during which subjects performed no exercise (control [▫]) or 60 min
of cycling exercise (50% Wmax) distributed either as a single session per 2 days (nondaily
[-]) or as 30 min per day (daily [G]). *Signiﬁcantly different compared with the control trial
(P , 0.05).
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performed every other day to improve
glycemic control in type 2 diabetic patients.
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